Stock News - CITIUS ONCOLOGY, INC. $CTOR

Latest Stock News for $CTOR
Citius Oncology Reports Strong Early Adoption of LYMPHIR™ with Expanding Clinical Development

Expected Stock impact: Noticeably Positive
2026-03-31 20:42:11